Glen Eagle Advisors’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.31M | Sell |
15,499
-538
| -3% | -$120K | 0.46% | 41 |
|
|
2025
Q4 | $2.75M | Buy |
16,037
+438
| +3% | +$68.1K | 0.37% | 51 |
|
|
2025
Q3 | $2.09M | Buy |
15,599
+79
| +0.5% | +$8.37K | 0.29% | 63 |
|
|
2025
Q2 | $1.51M | Sell |
15,520
-348
| -2% | -$27.6K | 0.23% | 79 |
|
|
2025
Q1 | $1.15M | Buy |
+15,868
| New | +$1.25M | 0.19% | 90 |
|
|
2024
Q4 | – | Sell |
-16,660
| Closed | -$1.36M | – | 1141 |
|
|
2024
Q3 | $1.36M | Sell |
16,660
-1,000
| -6% | -$86.9K | 0.23% | 79 |
|
|
2024
Q2 | $1.88M | Sell |
17,660
-770
| -4% | -$73.8K | 0.34% | 60 |
|
|
2024
Q1 | $1.79M | Buy |
18,430
+1,980
| +12% | +$174K | 0.34% | 62 |
|
|
2023
Q4 | $1.29M | Buy |
16,450
+670
| +4% | +$45.7K | 0.27% | 75 |
|
|
2023
Q3 | $989K | Buy |
15,780
+40
| +0.3% | +$2.63K | 0.23% | 91 |
|
|
2023
Q2 | $1.01M | Sell |
15,740
-340
| -2% | -$19.2K | 0.23% | 90 |
|
|
2023
Q1 | $852K | Sell |
16,080
-150
| -0.9% | -$7.36K | 0.21% | 90 |
|
|
2022
Q4 | $682K | Sell |
16,230
-1,810
| -10% | -$75.7K | 0.19% | 103 |
|
|
2022
Q3 | $660K | Buy |
18,040
+40
| +0.2% | +$1.78K | 0.19% | 104 |
|
|
2022
Q2 | $767K | Sell |
18,000
-2,290
| -11% | -$109K | 0.21% | 96 |
|
|
2022
Q1 | $1.09M | Buy |
20,290
+7,120
| +54% | +$414K | 0.28% | 75 |
|
|
2021
Q4 | $947K | Buy |
13,170
+1,150
| +10% | +$72.1K | 0.25% | 87 |
|
|
2021
Q3 | $684K | Buy |
12,020
+2,680
| +29% | +$163K | 0.2% | 113 |
|
|
2021
Q2 | $608K | Buy |
9,340
+2,270
| +32% | +$143K | 0.19% | 114 |
|
|
2021
Q1 | $421K | Buy |
7,070
+3,680
| +109% | +$201K | 0.15% | 124 |
|
|
2020
Q4 | $160K | Buy |
3,390
+450
| +15% | +$18.9K | 0.06% | 193 |
|
|
2020
Q3 | $97.7K | Buy |
2,940
+1,340
| +84% | +$46.2K | 0.04% | 224 |
|
|
2020
Q2 | $51.9K | Buy |
1,600
+1,190
| +290% | +$32.5K | 0.03% | 280 |
|
|
2020
Q1 | $9.92K | Buy |
410
+30
| +8% | +$864 | 0.01% | 511 |
|
|
2019
Q4 | $11.2K | Buy |
380
+130
| +52% | +$3.45K | 0.01% | 560 |
|
|
2019
Q3 | $5.79K | Hold |
250
| – | – | ﹤0.01% | 612 |
|
|
2019
Q2 | $4.7K | Buy |
+250
| New | +$4.74K | ﹤0.01% | 633 |
|
|
2018
Q1 | – | Sell |
-750
| Closed | -$13.8K | – | 695 |
|
|
2017
Q4 | $13.8K | Hold |
750
| – | – | 0.01% | 390 |
|
|
2017
Q3 | $13.9K | Hold |
750
| – | – | 0.01% | 388 |
|
|
2017
Q2 | $10.6K | Hold |
750
| – | – | 0.01% | 386 |
|
|
2017
Q1 | $9.63K | Hold |
750
| – | – | 0.01% | 378 |
|
|
2016
Q4 | $7.93K | Buy |
+750
| New | +$7.62K | 0.01% | 391 |
|
Other funds holding LRCX
VCM
VPM
Glen Eagle Advisors's LRCX Position: Q1 2026 in Review
Glen Eagle Advisors reduced its Lam Research (LRCX) stake by 3.4% in Q1 2026, selling an estimated $120K and leaving 15,499 shares worth $3.31M. The position accounts for 0.46% of the portfolio, ranked #41.
Glen Eagle Advisors first reported a position in LRCX in Q4 2016 and has held it in 32 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.
- Glen Eagle Advisors held 15,499 shares of Lam Research worth $3.31M as of Q1 2026.
- Glen Eagle Advisors sold 538 Lam Research shares in Q1 2026, an estimated $120K.
- Lam Research made up 0.46% of Glen Eagle Advisors's portfolio in Q1 2026, its #41 holding.
- Glen Eagle Advisors first reported a position in Lam Research in Q4 2016 and has held it in 32 quarters since.
- 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.